Quanterix Corporation Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
Quanterix Corporation (QTRX) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $340.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2026-08-10
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-06-30 was $0.00.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-03-31 was $340.00K, a 49.10% decline year-over-year.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-12-31 was -$192.00K, a 386.57% decline year-over-year.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-09-30 was $262.00K, a 54.67% decline year-over-year.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2025 was $738.00K, a 75.93% decline from fiscal 2024.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2024 was $3.07M, a 6.13% increase from fiscal 2023.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2023 was $2.89M, a 25.01% increase from fiscal 2022.
- Quanterix Corporation proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2022 was $2.31M, a 73.78% decline from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $340.00K 10-Q · filed 2026-08-10 | $148.00K derived: sum of 3 quarters · filed 2026-08-10 | $410.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $340.00K 10-Q · filed 2026-05-06 | $148.00K derived: sum of 2 quarters · filed 2026-05-06 | $410.00K derived: sum of 3 quarters · filed 2026-05-06 | $410.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $70.00K derived: sum of 2 quarters · filed 2026-03-02 | $70.00K derived: sum of 3 quarters · filed 2026-08-10 | $738.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $262.00K derived: sum of 2 quarters · filed 2026-08-10 | $930.00K 10-Q · filed 2025-11-10 | $997.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $668.00K 10-Q · filed 2026-08-10 | $735.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.31M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $668.00K 10-Q · filed 2026-05-06 | $735.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.31M derived: sum of 3 quarters · filed 2026-05-06 | $1.70M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $645.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.03M derived: sum of 3 quarters · filed 2026-03-02 | $3.07M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $962.00K derived: sum of 2 quarters · filed 2025-11-10 | $3.00M 10-Q · filed 2025-11-10 | $3.26M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-06-30 | $384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.42M 10-Q · filed 2025-08-07 | $2.68M derived: sum of 3 quarters · filed 2026-03-02 | $4.53M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2024-03-31 | $2.04M 10-Q · filed 2025-05-12 | $2.29M derived: sum of 2 quarters · filed 2026-03-02 | $4.15M derived: sum of 3 quarters · filed 2026-03-02 | $4.38M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $257.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02 | $2.11M derived: sum of 2 quarters · filed 2026-03-02 | $2.34M derived: sum of 3 quarters · filed 2026-03-02 | $2.89M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $1.85M derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $2.08M derived: sum of 2 quarters · filed 2024-12-26 | $2.63M 10-K/A · filed 2024-12-26 | $4.06M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-06-30 | $226.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | $777.00K 10-K/A · filed 2024-12-26 | $2.21M derived: sum of 3 quarters · filed 2025-03-17 | $2.49M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-03-31 | $551.00K 10-K/A · filed 2024-12-26 | $1.98M derived: sum of 2 quarters · filed 2025-03-17 | $2.27M derived: sum of 3 quarters · filed 2025-03-17 | $2.27M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2022-12-31 | $1.43M derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | $1.72M derived: sum of 2 quarters · filed 2025-03-17 | $1.72M derived: sum of 3 quarters · filed 2025-03-17 | $2.31M 10-K · filed 2025-03-17 | $881.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $287.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $287.00K derived: sum of 2 quarters · filed 2024-12-26 | $881.00K 10-K/A · filed 2024-12-26 | $8.63M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-06-30 | $0.00 derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | $594.00K 10-K/A · filed 2024-12-26 | $8.34M derived: sum of 3 quarters · filed 2024-12-26 | $8.89M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-03-31 | $594.00K 10-K/A · filed 2024-12-26 | $8.34M derived: sum of 2 quarters · filed 2024-12-26 | $8.89M derived: sum of 3 quarters · filed 2024-12-26 | $8.89M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2021-12-31 | $7.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $8.30M derived: sum of 2 quarters · filed 2024-12-26 | $8.30M derived: sum of 3 quarters · filed 2024-12-26 | $8.81M 10-K/A · filed 2024-12-26 | $1.06M 10-K · filed 2022-03-01 |
| 2021-09-30 | $546.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $546.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.06M 10-Q · filed 2022-11-09 | $1.06M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $519.00K 10-Q · filed 2022-08-08 | $519.00K derived: sum of 3 quarters · filed 2023-03-06 | $967.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | $519.00K 10-Q · filed 2022-05-10 | $519.00K derived: sum of 2 quarters · filed 2023-03-06 | $967.00K derived: sum of 3 quarters · filed 2023-03-06 | $967.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $448.00K derived: sum of 2 quarters · filed 2023-03-06 | $448.00K derived: sum of 3 quarters · filed 2023-03-06 | $888.00K 10-K · filed 2023-03-06 | |
| 2020-09-30 | $448.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $448.00K derived: sum of 2 quarters · filed 2021-11-04 | $888.00K 10-Q · filed 2021-11-04 | $968.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $440.00K 10-Q · filed 2021-08-05 | $520.00K derived: sum of 3 quarters · filed 2022-03-01 | $926.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $440.00K 10-Q · filed 2021-05-06 | $520.00K derived: sum of 2 quarters · filed 2022-03-01 | $926.00K derived: sum of 3 quarters · filed 2022-03-01 | $991.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $486.00K derived: sum of 2 quarters · filed 2022-03-01 | $551.00K derived: sum of 3 quarters · filed 2022-03-01 | $879.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $471.00K derived: sum of 2 quarters · filed 2020-11-06 | $799.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $393.00K 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | $328.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |